A detailed history of 55 I, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, 55 I, LLC holds 1,803 shares of REGN stock, worth $1.34 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,803
Holding current value
$1.34 Million
% of portfolio
0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $1.03 Million - $1.31 Million
1,803 New
1,803 $1.24 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track 55 I, LLC Portfolio

Follow 55 I, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 55 I, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 55 I, LLC with notifications on news.